Man Group plc Invests $5.70 Million in Chemed Corporation $CHE

Man Group plc bought a new stake in Chemed Corporation (NYSE:CHE) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 12,232 shares of the company’s stock, valued at approximately $5,697,000.

A number of other institutional investors and hedge funds also recently modified their holdings of CHE. Monetary Solutions Ltd bought a new stake in Chemed during the fourth quarter worth $25,000. Los Angeles Capital Management LLC bought a new position in Chemed in the 4th quarter valued at $26,000. BOK Financial Private Wealth Inc. bought a new position in Chemed in the 4th quarter valued at $27,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of Chemed during the 2nd quarter valued at $34,000. Finally, Versant Capital Management Inc increased its position in shares of Chemed by 7,500.0% during the 2nd quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock valued at $35,000 after purchasing an additional 75 shares during the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Chemed Stock Performance

NYSE CHE opened at $523.57 on Friday. The firm has a market cap of $6.84 billion, a P/E ratio of 26.30, a price-to-earnings-growth ratio of 1.98 and a beta of 0.51. The company has a quick ratio of 0.89, a current ratio of 0.91 and a debt-to-equity ratio of 0.17. The company’s 50 day moving average is $509.45 and its 200-day moving average is $449.67. Chemed Corporation has a 12-month low of $365.20 and a 12-month high of $557.00.

Chemed (NYSE:CHE) last released its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, topping the consensus estimate of $5.60 by $0.46. The company had revenue of $673.25 million during the quarter, compared to the consensus estimate of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. Chemed’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same period last year, the firm earned $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Sell-side analysts predict that Chemed Corporation will post 23.18 earnings per share for the current year.

Chemed Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be issued a dividend of $0.70 per share. This is a positive change from Chemed’s previous quarterly dividend of $0.60. The ex-dividend date of this dividend is Monday, August 17th. This represents a $2.80 dividend on an annualized basis and a yield of 0.5%. Chemed’s payout ratio is currently 14.06%.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on CHE. Wall Street Zen raised shares of Chemed from a “hold” rating to a “strong-buy” rating in a report on Saturday, August 1st. Weiss Ratings upgraded shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. Royal Bank Of Canada lifted their price objective on shares of Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a research report on Thursday, July 30th. Oppenheimer boosted their target price on shares of Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research note on Friday, July 31st. Finally, Bank of America reissued a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. One equities research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, Chemed currently has an average rating of “Hold” and an average price target of $530.75.

Insider Buying and Selling

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $539.51, for a total transaction of $1,079,020.00. Following the sale, the chief executive officer directly owned 70,418 shares in the company, valued at $37,991,215.18. This represents a 2.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Patrick P. Grace sold 190 shares of the stock in a transaction dated Friday, July 31st. The stock was sold at an average price of $532.00, for a total transaction of $101,080.00. Following the completion of the sale, the director directly owned 3,533 shares in the company, valued at approximately $1,879,556. The trade was a 5.10% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 6,537 shares of company stock worth $3,406,014 in the last 90 days. 3.33% of the stock is owned by company insiders.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.